Cadrenal Therapeutics, Inc.
A late-stage biopharmaceutical company developing novel anticoagulation therapeutics.
CVKD | US
Overview
Corporate Details
- ISIN(s):
- US1276361086
- LEI:
- Country:
- United States of America
- Address:
- 822 A1A NORTH, 32082 PONTE VEDRA
- Website:
- https://www.cadrenal.com/
- Sector:
- Manufacturing
Description
Cadrenal Therapeutics, Inc. is a late-stage biopharmaceutical company developing novel anticoagulation therapeutics to address critical gaps in the treatment of cardiovascular diseases. The company's clinical-stage portfolio targets both chronic and acute care settings. Its lead candidate, tecarfarin, is an oral vitamin K antagonist (VKA) designed to provide more stable and predictable anticoagulation for high-risk patients, including those with end-stage kidney disease (ESKD) and atrial fibrillation or with implanted cardiac devices. The company is also advancing frunexian, a parenteral small-molecule Factor XIa inhibitor, for use in acute hospital settings such as complex cardiac surgeries. Cadrenal aims to improve standards of care by developing therapies with fewer bleeding complications for underserved patient populations.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Cadrenal Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Cadrenal Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Cadrenal Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
